Dr. Kabour Promise
Dr. Kabour was a leading force in research, where he believes in advancing sciences and also using updated technology to help communities live better and healthier.
See our list of research involvement
We pledge to always put patients and the community first. That means being leaders in research to help find the cure foa all heart disease
Dr. Kabour Latest Publications
Kritika Luthra, Jay Shah, Muhammad Khan…..Ameer Kabour, Et al. The In-Hospital Outcomes of Atherectomy for Peripheral Arterial Disease Among Obese and Non-Obese Patients: An Insight from the National Inpatient Sample Database.
Journal of the Society for Cardiovascular Angiography & Interventions 2(3):100848
May 2023
Gregg W. Stone, Dean J. Kareiakes,…..Ameer Kabour…etal Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial
Journal of the Society for Cardiovascular Angiography & Interventions 2(3):100848
May 2023
Raviteja R. Guddeti, MD1; Cristina Sanina, MD2; ........Ameer Kabour, MD18 ; et al. Mechanical Circulatory Support in COVID-19 Patients Presenting with Myocardial Infarction: Insights from the North American COVID-19 Myocardial Infarction Registry.
The American Journal of Cardiology 187:76-83
Jan 2023
Odayme Quesada, Mehmet Yildiz,….Ameer Kabour,..et al. Abstract 12740: Racial and Ethnic Disparities in Mortality in Patients Presenting With STEMI With COVID-19: NACMI Registry
Circulation 146(Suppl_1)
Nov 2022
Jay Shah, Kritika Luthra,….Ameer Kabour,….et al. Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease—insight from the National Inpatient Sample database.
Proceedings (Baylor University. Medical Center) 35(5):1-5.
July 2022
Mobassar Mahmood, …. Ameer Kabour, et al. Management of Right Atrial Thrombus During MitraClip Implantation: A Case Report and Review of Literature.
Cardiovascular Revascularization Medicine 47(24)
May 2022
Ghulam Mujtaba Ghumman, …..Ameer Kabour, etal. A CABG complication - LIMA graft to cardiac venous system anastomosis rescued by percutaneous coronary intervention.
Cardiovascular Revascularization Medicine
May 2022
Santiago Garcia, MD, Payam Dehghani, MD,….Ameer Kabour, MD,…etal. Trends in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19.
Journal of the American College of Cardiology 79(22)
April 2022
Focus on angioplasty and stents devices research to improve the technology used to treat heart disease and improve outcomes.
Dr. Kabour was a lead enroller in many current available stent research before approved in the market with many organization, including Boston Scientific, Abbott, Biotronic, and many others....
Intravascular Research
01
Focus on management of heart failure with medications and devices.
Dr. kabour was involved in studies to improve survival, treatment of heart failure currently available, including Ace Inhibitor, Entresto, and many others.
Heart Failure Treatments
02
Focus on technology to be used in advancing heart disease management.
Dr. Kabour was involved in Leads investigations used for devices (AICD implants- Medtronic), also in early ischemia detection (Angle Alert), and the latest in heart stimulator (Impulse Dynamic) to improve patient CHF symptoms, recovery and survival.
Devices Investigations
03
Focus on identifying and managing the COVID-19 effect on the heart.
Dr. Kabour was involved in the first studies to report increase heart attach in Covid-19 patient and best available management.
North American COVID-19 Acute MI Registry
COVID-19 & Heart Attacks
04
Focus on new technology where the stent absorbed after a period of time. (Abbott)
Dr. kabour was part of this continuous research to improve outcome of vascular stents and provide a better treatments for CAD.
Advanced Absorbable Stents
05
